TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 46 filers reported holding TYRA BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,389,948 | -19.1% | 1,989,103 | 0.0% | 4.03% | -27.4% |
| Q2 2023 | $33,874,424 | +6.0% | 1,989,103 | 0.0% | 5.56% | -10.8% |
| Q1 2023 | $31,964,885 | +111.4% | 1,989,103 | 0.0% | 6.23% | +133.5% |
| Q4 2022 | $15,117,183 | +81.8% | 1,989,103 | +110.3% | 2.67% | +7.0% |
| Q3 2022 | $8,313,000 | +29.7% | 945,707 | +5.5% | 2.49% | -8.4% |
| Q2 2022 | $6,409,000 | -33.2% | 896,418 | 0.0% | 2.72% | -29.3% |
| Q1 2022 | $9,592,000 | -19.8% | 896,418 | +5.4% | 3.85% | -31.3% |
| Q4 2021 | $11,966,000 | – | 850,450 | – | 5.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $75,102,147 | 53.19% |
| Nextech Invest Ltd. | 2,518,582 | $42,891,451 | 14.58% |
| TCG Crossover Management, LLC | 1,989,103 | $33,874,424 | 5.56% |
| Boxer Capital, LLC | 6,448,359 | $109,816 | 5.09% |
| Fairmount Funds Management LLC | 1,416,998 | $24,131,476 | 3.40% |
| RA Capital Management | 7,236,454 | $123,236,812 | 2.33% |
| BVF INC/IL | 2,739,595 | $46,655,303 | 1.30% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $17,507,061 | 1.05% |
| Auour Investments LLC | 85,020 | $1,447,891 | 0.62% |
| Artia Global Partners LP | 45,253 | $770,659 | 0.27% |